潜在肾损伤暴露后急性肾损伤尿液细胞周期停滞标志物的动力学
该研究为多中心SAPPHIRE研究的辅助分析,纳入北美和欧洲35个中心2010年9月至2012年6月收治的723例ICU成人患者,无干预。679例(94%)至少有一种、70%有一种以上、35%有三种及以上已知肾损伤暴露。截至研究第3天,累积暴露次数与AKI风险显著相关(p=0.02),但特定暴露类型与AKI无关联(p=0.22)。除造影剂外,五种暴露后发生AKI 2-3期的患者,尿[TIMP-2]•[IGFBP7]从暴露当天至24–48小时后有明显升高和回落;未发生AKI者该标志物无显著升高。
要点
- 723例ICU成人中679例(94%)至少有一种潜在肾损伤暴露,70%有一种以上,35%有三种及以上。
- 截至研究第3天累积暴露次数与AKI风险显著相关(p=0.02),特定暴露类型与AKI无关联(p=0.22)。
- 除造影剂外,五种暴露后发生AKI 2-3期者,尿[TIMP-2]•[IGFBP7]从暴露当天至24–48小时后明显升高并回落。
- 未发生AKI的患者尿[TIMP-2]•[IGFBP7]无显著升高。
- 暴露于潜在肾损伤因素在ICU患者中常见,尿标志物动力学可与暴露时间对应解读。
适用人群与场景
- ICU收治的危重成人患者,纳入723例。
- 暴露因素包括大手术、静脉造影剂、万古霉素、非甾体抗炎药、哌拉西林/他唑巴坦。
诊断标准与关键阈值
- AKI分期采用肾脏疾病改善全球结局(KDIGO)标准,分为2-3期、1期或无AKI。
研究设计与关键结果
- 多中心辅助分析,35个中心,723例ICU成人,2010年9月至2012年6月,无干预。
- 679例(94%)至少有一种暴露,70%有一种以上,35%有三种及以上。
- 截至研究第3天累积暴露次数与AKI风险显著相关(p=0.02),特定暴露类型与AKI无关联(p=0.22)。
- 除造影剂外,五种暴露后发生AKI 2-3期者,尿[TIMP-2]•[IGFBP7]从暴露当天至24–48小时后明显升高并回落;无AKI者无显著升高。
证据类型、等级与局限
- 证据类型:多中心SAPPHIRE研究的辅助分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尿[TIMP-2]•[IGFBP7]动力学可与暴露时间对应解读,但造影剂暴露后不符合此规律。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 predict the development of acute kidney injury following renal insults of varied aetiology. To aid clinical interpretation, we describe the kinetics of biomarker elevations around an exposure.
DESIGN: In an ancillary analysis of the multicenter SAPPHIRE study, we examined the kinetics of the urinary [tissue inhibitor of metalloproteinase-2]•[insulin-like growth factor binding protein 7] in association with exposure to common renal insults (major surgery, IV radiocontrast, vancomycin, nonsteroidal anti-inflammatory drugs, and piperacillin/tazobactam).
SETTING: Thirty-five sites in North America and Europe between September 2010 and June 2012.
PATIENTS: Seven hundred twenty-three critically ill adult patients admitted to the ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We compared the urinary [tissue metalloproteinase-2]•[insulin growth factor binding protein 7] kinetics from the day prior to exposure up to 5 days after exposure in patients developing acute kidney injury stage 2-3, stage 1, or no acute kidney injury by Kidney Disease Improving Global Outcome criteria. Among the 723 patients, 679 (94%) had at least one, 70% had more than one, and 35% had three or more exposures to a known renal insult. There was a significant association between cumulative number of exposures up to study day 3 and risk of acute kidney injury (p = 0.02) but no association between the specific type of exposure and acute kidney injury (p = 0.22). With the exception of radiocontrast, patients who developed acute kidney injury stage 2-3 after one of the five exposures, had a clear rise and fall of urinary [tissue inhibitor of metalloproteinase-2]•[insulin-like growth factor binding protein 7] from the day of exposure to 24-48 hours later. In patients without acute kidney injury, there was no significant elevation in urinary [tissue inhibitor of metalloproteinase-2]•[insulin-like growth factor binding protein 7].
CONCLUSIONS: Exposure to potential renal insults is common. In patients developing acute kidney injury stage 2-3, the kinetics of urinary [tissue inhibitor of metalloproteinase-2]•[insulin-like growth factor binding protein 7] matched the exposure except in the case of radiocontrast.
参考来源
- Ostermann M, McCullough PA, Forni LG, et al. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults. Crit Care Med. 2018. PMID: 29189343. doi:10.1097/CCM.0000000000002847
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。